Prevalence and Patterns of Antibiotic Prescribing in Italian Hospitals

Infection, Supplement

Volumn 31, Issue 2, 2003, Pages 16-21

  Porretta, A ^a   Giuliani, L ^b   Vegni, F E ^d   Larosa, M ^c   Privitera, G ^a  

^a UNIVERSITY OF PISA   (Italy)

^b University Hospital Maggiore della Carita   (Italy)

^c GSK   (Italy)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIFUNGAL AGENT; ANTIMYCOBACTERIAL AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; STREPTOGRAMIN; SULBACTAM; SULFONAMIDE; TEICOPLANIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL ACTIVITY; CONFERENCE PAPER; DRUG USE; HEALTH SURVEY; HOSPITAL; HUMAN; INFECTION; ITALY; MEDICAL RECORD; PRESCRIPTION; PREVALENCE; PROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HOSPITALS; HUMANS; INFECTION CONTROL; ITALY; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE;

EID: 0442276266     PISSN: 01732129     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. World Health Organization. Overcoming antimicrobial resistance: world health report on infectious diseases 2000. www.who.int/infectious-disease- report/2000 (accessed 9 Aug 2002).
2. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999;96:1152-1156.
3. U.S. Congress, Office of Technology Assessment. Impacts of antibiotic-resistant bacteria. OTA-H-29. Washington DC. U.S. Goverment Printing Office, 1995.
4. Lew DP, Garbino J, Gerber AU, Sudre P, the Swiss Committee of Anti-infective Agents. Use of antimicrobials in Swiss hospitals. Drugs 1996;52(Suppl. 2):88-91.
5. Carling PA, Fung T, Coldiron JS. Parenteral antibiotic use in acute-care hospitals: a standardized analysis of fourteen institutions. Clin Infect Dis 1999;29:1189-1196.
6. Bassetti M, Di Biagio A, Rebesco B, Amalfitano ME, Topal J, Bassetti D. The effect of formulary restriction in the use of antibiotics in an Italian hospital. Eur J Clin Pharmacol 2001;57:529-534.
7. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997;24:211-215.
8. Monnet DL, Archibald LK, Phillips L, Tenover FC, McGowan JE Jr, Gaynes R: Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Infect Control Hosp Epidemiol 1998;19:388-394.
9. Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB: Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343:1925-1932.
10. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C: Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997 25:584-599.
11. Duncan RA: Controlling use of antimicrobial agents. Infect Control Hosp Epidemiol 1997;18:260-266.
12. Weinstein RA: Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis 2001;7:188-192.
13. Dickerson LM, Mainous AG, Carek PJ: The pharmacist's role in promoting optimal antimicrobial use. Pharmacotherapy 2000;20:711-723.
14. Marr JJ, Moffet H, Kunin CM: Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Disease Society of America. J Infect Dis 1998;157:869-876.
15. WHO Collaborating Centre for Drug Statistics Methodology: Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs). Oslo: 2002.
16. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
17. Kern WV, Rose AD, Hay B, Muche R, Frank U and the Baden Wurttemberg Interuniversity Study Group: Antimicrobial expenditures and usage at four university hospitals. Infection 2001;29:127-137.
18. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, Gaynes RP, Tenover FC, and Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Hospitals: Surveillance of antimicrobial use and antimicrobial resistance in United States Hospitals: Project ICARE Phase 2. Clin Infect Dis 1999;29:245-252.
19. Manian FA, Meyer L, Jenne J, Owen A, Taff J: Loss of antimicrobial susceptibility in aerobic gram negative bacilli isolated from patients in ICUs. Infect Contr Hosp Epidemiol 1996;17:222-226.
20. Lang A, De Fina G, Meyer R, Aschbacher R, Rizza F, Mayr O, Casini M: Comparison of antimicrobial use and resistance of bacterial isolates in a haematology ward and an intensive care unit. Eur J Clin Microbiol Infect Dis 2001;20:657-660.
21. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC Duma RJ, Gaynes RP, Schlosser J, Martone WJ: Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996;275:234-240.
22. Cooke DM, Salter AJ, Phillips I: The impact of antibiotic policy on prescribing in a London teaching hospital. A one-day prevalence survey as an indicator of antibiotic use. J Antimicrob Chemother 1983;11:447-453.
23. Von Gunten V, Reymond J-P, Troillet N: Use of broad spectrum antibiotics in six non-university Swiss hospitals. Swiss Med Wkly 2001;131:438-441.
24. Burke JP, Pestotnik SL: The quality of antibiotic use and the quality of measuring it. Curr Opin Infect Dis 1997;10:289-291.
25. Davey PG, Malek M: Defining criteria for the pharmacoeconomic evaluation of new oral cephalosporins. Pharmacoeconomics 1994;5 (Suppl. 2):11-19.
26. Le Lorier J: Counting the cost of antibiotic therapy from different perspectives: a major issue for the '90s. Eur Resp Rev 1994;22:333-335.